{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:30:55Z","timestamp":1791217855227,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T00:00:00Z","timestamp":1732924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T00:00:00Z","timestamp":1732924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"EAS Competitive Grant","award":["LDD"],"award-info":[{"award-number":["LDD"]}]},{"name":"Progetti di Rilevante Interesse Nazionale","award":["(PRIN-PNRR 2022 P202294PHK to AB)"],"award-info":[{"award-number":["(PRIN-PNRR 2022 P202294PHK to AB)"]}]},{"name":"Progetti di Rilevante Interesse Nazionale","award":["(PRIN 2022 2022NBKCWP to FB)"],"award-info":[{"award-number":["(PRIN 2022 2022NBKCWP to FB)"]}]},{"name":"Progetti di Rilevante Interesse Nazionale","award":["(PRIN 2022 7KTSAT to GDN)"],"award-info":[{"award-number":["(PRIN 2022 7KTSAT to GDN)"]}]},{"name":"Dutch Research Council (NWO) in the framework of the ENW PPP Fund for the top sectors","award":["(project Proteoform-resolved pharmacokinetics of biopharmaceuticals, no. 019.012)"],"award-info":[{"award-number":["(project Proteoform-resolved pharmacokinetics of biopharmaceuticals, no. 019.012)"]}]},{"name":"Dutch Research Council (NWO) in the framework of the ENW PPP Fund for the top sectors","award":["(project Proteoform-resolved pharmacokinetics of biopharmaceuticals, no. 019.012)"],"award-info":[{"award-number":["(project Proteoform-resolved pharmacokinetics of biopharmaceuticals, no. 019.012)"]}]},{"name":"Nanokos","award":["(European Commission Ref EUROPEAID\/173691\/DD\/ACT\/XK to GDN, GB)"],"award-info":[{"award-number":["(European Commission Ref EUROPEAID\/173691\/DD\/ACT\/XK to GDN, GB)"]}]},{"name":"Nanokos","award":["(European Commission Ref EUROPEAID\/173691\/DD\/ACT\/XK to GDN, GB)"],"award-info":[{"award-number":["(European Commission Ref EUROPEAID\/173691\/DD\/ACT\/XK to GDN, GB)"]}]},{"DOI":"10.13039\/501100002803","name":"Fondazione Cariplo","doi-asserted-by":"publisher","award":["(1560-2019 to FB)"],"award-info":[{"award-number":["(1560-2019 to FB)"]}],"id":[{"id":"10.13039\/501100002803","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fondazione Roche","award":["(2022 to FB)"],"award-info":[{"award-number":["(2022 to FB)"]}]},{"name":"Ricerca Finalizzata, Ministry of Health","award":["(RF-2019-12370896 to GDN)"],"award-info":[{"award-number":["(RF-2019-12370896 to GDN)"]}]},{"name":"PNRR Missione 4","award":["(Progetto CN3 - National Center for Gene Therapy and Drugs based on RNA Technology to GDN)"],"award-info":[{"award-number":["(Progetto CN3 - National Center for Gene Therapy and Drugs based on RNA Technology to GDN)"]}]},{"name":"PNRR Missione 6","award":["(PNRR-MAD-2022-12375913 to GDN)"],"award-info":[{"award-number":["(PNRR-MAD-2022-12375913 to GDN)"]}]},{"name":"CARDINNOV, Ministry of Research and University under the umbrella of the Partnership Fostering a European Research Area for Health","award":["(GA N\u00b0 101095426 of the EU Horizon Europe Research and Innovation Programme to GDN)"],"award-info":[{"award-number":["(GA N\u00b0 101095426 of the EU Horizon Europe Research and Innovation Programme to GDN)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>\n                      The asialoglycoprotein receptor 1 (ASGR1), a multivalent carbohydrate-binding receptor that primarily is responsible for recognizing and eliminating circulating glycoproteins with exposed galactose (Gal) or\n                      <jats:italic>N<\/jats:italic>\n                      -acetylgalactosamine (GalNAc) as terminal glycan residues, has been implicated in modulating the lipid metabolism and reducing cardiovascular disease burden. In this study, we investigated the impact of ASGR1 deficiency (ASGR1\n                      <jats:sup>\u2212\/\u2212)<\/jats:sup>\n                      on atherosclerosis by evaluating its effects on plaque formation, lipid metabolism, circulating immunoinflammatory response, and circulating\n                      <jats:italic>N<\/jats:italic>\n                      -glycome under the hypercholesterolemic condition in ApoE-deficient mice. After 16 weeks of a western-type diet, ApoE\n                      <jats:sup>\u2212\/\u2212<\/jats:sup>\n                      \/ASGR1\n                      <jats:sup>\u2212\/\u2212<\/jats:sup>\n                      mice presented lower plasma cholesterol and triglyceride levels compared to ApoE\n                      <jats:sup>\u2212\/\u2212<\/jats:sup>\n                      . This was associated with reduced atherosclerotic plaque area and necrotic core formation. Interestingly, ApoE\n                      <jats:sup>\u2212\/\u2212<\/jats:sup>\n                      \/ASGR1\n                      <jats:sup>\u2212\/\u2212<\/jats:sup>\n                      mice showed increased levels of circulating immune cells, increased AST\/ALT ratio, and no changes in the\n                      <jats:italic>N<\/jats:italic>\n                      -glycome profile and liver morphology. The liver of ApoE\n                      <jats:sup>\u2212\/\u2212<\/jats:sup>\n                      \/ASGR1\n                      <jats:sup>\u2212\/\u2212<\/jats:sup>\n                      mice, however, presented alterations in the metabolism of lipids, xenobiotics, and bile secretion, indicating broader alterations in liver homeostasis beyond lipids. These data suggest that improvements in circulating lipid metabolism and atherosclerosis in ASGR1 deficiency is paralleled by a deterioration of liver injury. These findings point to the need for additional evaluation before considering ASGR1 as a pharmacological target for dyslipidemia and cardiovascular disorders.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s12933-024-02507-5","type":"journal-article","created":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T07:28:09Z","timestamp":1732951689000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["ASGR1 deficiency improves atherosclerosis but alters liver metabolism in ApoE-\/- mice"],"prefix":"10.1186","volume":"23","author":[{"given":"Monika","family":"Svecla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Moregola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo Da","family":"Dalt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Nour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Baragetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Uboldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Idini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Wuhrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giangiacomo","family":"Beretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Falck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizia","family":"Bonacina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe Danilo","family":"Norata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,30]]},"reference":[{"key":"2507_CR1","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/nm.2538","volume":"17","author":"C Weber","year":"2011","unstructured":"Weber C, Noels H. Atherosclerosis: current pathogenesis and therapeutic options. Nat Med. 2011;17:1410\u201322.","journal-title":"Nat Med"},{"key":"2507_CR2","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1093\/cvr\/cvz003","volume":"115","author":"NG Seidah","year":"2019","unstructured":"Seidah NG, Prat A, Pirillo A, Catapano AL, Norata G. D. Novel strategies to target proprotein convertase subtilisin kexin 9: beyond monoclonal antibodies. Cardiovasc Res. 2019;115:510\u20138.","journal-title":"Cardiovasc Res"},{"key":"2507_CR3","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1161\/CIRCRESAHA.117.312086","volume":"122","author":"P van der Harst","year":"2018","unstructured":"van der Harst P, Verweij N. Identification of 64 Novel genetic loci provides an expanded view on the Genetic Architecture of Coronary Artery Disease. Circ Res. 2018;122:433\u201343.","journal-title":"Circ Res"},{"key":"2507_CR4","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1016\/j.cell.2022.04.004","volume":"185","author":"JLM Bj\u00f6rkegren","year":"2022","unstructured":"Bj\u00f6rkegren JLM, Lusis AJ. Atherosclerosis: recent developments. Cell. 2022;185:1630\u201345.","journal-title":"Cell"},{"key":"2507_CR5","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1056\/NEJMoa1508419","volume":"374","author":"P Nioi","year":"2016","unstructured":"Nioi P, et al. Variant ASGR1 Associated with a reduced risk of coronary artery disease. N Engl J Med. 2016;374:2131\u201341.","journal-title":"N Engl J Med"},{"key":"2507_CR6","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jconrel.2015.02.022","volume":"203","author":"AA D\u2019Souza","year":"2015","unstructured":"D\u2019Souza AA, Devarajan PV. Asialoglycoprotein receptor mediated hepatocyte targeting \u2014 strategies and applications. J Control Release. 2015;203:126\u201339.","journal-title":"J Control Release"},{"key":"2507_CR7","doi-asserted-by":"publisher","first-page":"13657","DOI":"10.1073\/pnas.1515464112","volume":"112","author":"WH Yang","year":"2015","unstructured":"Yang WH, et al. An intrinsic mechanism of secreted protein aging and turnover. Proc Natl Acad Sci U S A. 2015;112:13657\u201362.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2507_CR8","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1146\/annurev.bi.51.070182.002531","volume":"51","author":"G Ashwell","year":"1982","unstructured":"Ashwell G, Harford J. Carbohydrate-specific receptors of the liver. Annu Rev Biochem. 1982;51:531\u201354.","journal-title":"Annu Rev Biochem"},{"key":"2507_CR9","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1161\/ATVBAHA.121.316290","volume":"41","author":"EAL Biessen","year":"2021","unstructured":"Biessen EAL, Van Berkel TJC. N-Acetyl galactosamine targeting: paving the way for clinical application of Nucleotide Medicines in Cardiovascular diseases. Arterioscler Thromb Vasc Biol. 2021;41:2855\u201365.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2507_CR10","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","volume":"622","author":"BB Sun","year":"2023","unstructured":"Sun BB, et al. Plasma proteomic associations with genetics and health in the UK Biobank. Nature. 2023;622:329\u201338.","journal-title":"Nature"},{"key":"2507_CR11","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1093\/cvr\/cvaa252","volume":"117","author":"A Pirillo","year":"2021","unstructured":"Pirillo A, Svecla M, Catapano AL, Holleboom AG, Norata GD. Impact of protein glycosylation on lipoprotein metabolism and atherosclerosis. Cardiovasc Res. 2021;117:1033\u201345.","journal-title":"Cardiovasc Res"},{"key":"2507_CR12","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s41586-022-05006-3","volume":"608","author":"JQ Wang","year":"2022","unstructured":"Wang JQ, et al. Inhibition of ASGR1 decreases lipid levels by promoting cholesterol excretion. Nature. 2022;608:413\u201320.","journal-title":"Nature"},{"key":"2507_CR13","doi-asserted-by":"crossref","unstructured":"Xu Y et al. Hypomorphic ASGR1 modulates lipid homeostasis via INSIG1-mediated SREBP signaling suppression. JCI Insight. 2021;6(19):e147038.","DOI":"10.1172\/jci.insight.147038"},{"key":"2507_CR14","doi-asserted-by":"crossref","unstructured":"Xie B et al. Deficiency of ASGR1 in pigs recapitulates reduced risk factor for cardiovascular disease in humans. PLoS Genet. 2021;17(11):e1009891.","DOI":"10.1371\/journal.pgen.1009891"},{"key":"2507_CR15","doi-asserted-by":"crossref","unstructured":"Wei M, Wang PG. Chapter Two - Desialylation in physiological and pathological processes: New target for diagnostic and therapeutic development. In: Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part A (ed. Zhang, L. B. T.-P. in M. B. and T. S.) vol. 162 25\u201357A. cademic Press (2019).","DOI":"10.1016\/bs.pmbts.2018.12.001"},{"key":"2507_CR16","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1093\/cvr\/cvad169","volume":"119","author":"L Da Dalt","year":"2023","unstructured":"Da Dalt L, et al. The inhibition of inner mitochondrial fusion in hepatocytes reduces non-alcoholic fatty liver and improves metabolic profile during obesity by modulating bile acid conjugation. Cardiovasc Res. 2023;119:2917\u201329.","journal-title":"Cardiovasc Res"},{"key":"2507_CR17","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1002\/hep.32709","volume":"78","author":"W van Zwol","year":"2023","unstructured":"van Zwol W, et al. Loss of hepatic SMLR1 causes hepatosteatosis and protects against atherosclerosis due to decreased hepatic VLDL secretion. Hepatology. 2023;78:1418\u201332.","journal-title":"Hepatology"},{"key":"2507_CR18","doi-asserted-by":"publisher","first-page":"e202202011","DOI":"10.1083\/jcb.202202011","volume":"221","author":"F Bonacina","year":"2022","unstructured":"Bonacina F, et al. The low-density lipoprotein receptor\u2013mTORC1 axis coordinates CD8\u2009+\u2009T cell activation. J Cell Biol. 2022;221:e202202011.","journal-title":"J Cell Biol"},{"key":"2507_CR19","doi-asserted-by":"publisher","first-page":"155576","DOI":"10.1016\/j.metabol.2023.155576","volume":"144","author":"A Baragetti","year":"2023","unstructured":"Baragetti A, et al. Neutrophil aging exacerbates high fat diet induced metabolic alterations. Metabolism. 2023;144:155576.","journal-title":"Metabolism"},{"key":"2507_CR20","doi-asserted-by":"publisher","first-page":"4080","DOI":"10.1021\/acs.jproteome.5b00538","volume":"14","author":"MR Bladergroen","year":"2015","unstructured":"Bladergroen MR, et al. Automation of high-throughput Mass Spectrometry-based plasma N-Glycome analysis with linkage-specific sialic acid esterification. J Proteome Res. 2015;14:4080\u20136.","journal-title":"J Proteome Res"},{"key":"2507_CR21","doi-asserted-by":"publisher","first-page":"5784","DOI":"10.1021\/ac500335t","volume":"86","author":"KR Reiding","year":"2014","unstructured":"Reiding KR, Blank D, Kuijper DM, Deelder AM, Wuhrer M. High-throughput profiling of protein N-Glycosylation by MALDI-TOF-MS employing linkage-specific sialic acid esterification. Anal Chem. 2014;86:5784\u201393.","journal-title":"Anal Chem"},{"key":"2507_CR22","doi-asserted-by":"publisher","first-page":"11955","DOI":"10.1021\/acs.analchem.8b02391","volume":"90","author":"GCM Vreeker","year":"2018","unstructured":"Vreeker GCM, et al. Automated plasma glycomics with linkage-specific sialic acid esterification and Ultrahigh Resolution MS. Anal Chem. 2018;90:11955\u201361.","journal-title":"Anal Chem"},{"key":"2507_CR23","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/nbt.2377","volume":"30","author":"MC Chambers","year":"2012","unstructured":"Chambers MC, et al. A cross-platform toolkit for mass spectrometry and proteomics. Nat Biotechnol. 2012;30:918\u201320.","journal-title":"Nat Biotechnol"},{"key":"2507_CR24","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nmeth.3959","volume":"13","author":"HL R\u00f6st","year":"2016","unstructured":"R\u00f6st HL, et al. OpenMS: a flexible open-source software platform for mass spectrometry data analysis. Nat Methods. 2016;13:741\u20138.","journal-title":"Nat Methods"},{"key":"2507_CR25","doi-asserted-by":"publisher","first-page":"2000319","DOI":"10.1002\/pmic.202000319","volume":"21","author":"M Svecla","year":"2021","unstructured":"Svecla M, et al. An open-source, multiple peptide sequencing strategy for label free quantification based on an OpenMS pipeline in the KNIME analytics platform. Proteomics. 2021;21:2000319.","journal-title":"Proteomics"},{"key":"2507_CR26","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1021\/acs.jproteome.4c00082","volume":"23","author":"V Bianco","year":"2024","unstructured":"Bianco V, et al. Regional differences in the Small Intestinal Proteome of Control Mice and of mice lacking lysosomal acid lipase. J Proteome Res. 2024;23:1506\u201318.","journal-title":"J Proteome Res"},{"key":"2507_CR27","doi-asserted-by":"publisher","first-page":"W216","DOI":"10.1093\/nar\/gkac194","volume":"50","author":"BT Sherman","year":"2022","unstructured":"Sherman BT, et al. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 2022;50:W216\u201321.","journal-title":"Nucleic Acids Res"},{"key":"2507_CR28","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","volume":"30","author":"A Kr\u00e4mer","year":"2014","unstructured":"Kr\u00e4mer A, Green J, Pollard Jr J, Tugendreich S. Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics. 2014;30:523\u201330.","journal-title":"Bioinformatics"},{"key":"2507_CR29","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.athplu.2022.12.001","volume":"51","author":"R Bellini","year":"2023","unstructured":"Bellini R, et al. Dendritic cell marker Clec4a4 deficiency limits atherosclerosis progression. Atheroscler Plus. 2023;51:8\u201312.","journal-title":"Atheroscler Plus"},{"key":"2507_CR30","first-page":"389","volume":"16","author":"M B\u00e4ck","year":"2019","unstructured":"B\u00e4ck M, Yurdagul A, Tabas I, \u00d6\u00f6rni K, Kovanen PT. Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities. Nat Rev Cardiol. 2019;16:389\u2013406.","journal-title":"Nat Rev Cardiol"},{"key":"2507_CR31","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nm1760","volume":"14","author":"PK Grewal","year":"2008","unstructured":"Grewal PK, et al. The Ashwell receptor mitigates the lethal coagulopathy of sepsis. Nat Med. 2008;14:648\u201355.","journal-title":"Nat Med"},{"key":"2507_CR32","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1161\/CIRCRESAHA.114.302426","volume":"114","author":"Y D\u00f6ring","year":"2014","unstructured":"D\u00f6ring Y, et al. Deficiency of the sialyltransferase St3Gal4 reduces Ccl5-mediated myeloid cell recruitment and arrest: short communication. Circ Res. 2014;114:976\u201381.","journal-title":"Circ Res"},{"key":"2507_CR33","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1093\/glycob\/cwy113","volume":"29","author":"ME Taylor","year":"2019","unstructured":"Taylor ME, Snelling T, Smith DF, Drickamer K. Absence of a human ortholog of rodent Kupffer cell galactose-binding receptor encoded by the CLEC4f gene. Glycobiology. 2019;29:332\u201345.","journal-title":"Glycobiology"},{"key":"2507_CR34","doi-asserted-by":"publisher","first-page":"C1","DOI":"10.1093\/glycob\/cwj126","volume":"16","author":"PJ Coombs","year":"2006","unstructured":"Coombs PJ, Taylor ME, Drickamer K. Two categories of mammalian galactose-binding receptors distinguished by glycan array profiling. Glycobiology. 2006;16:C1\u20137.","journal-title":"Glycobiology"},{"key":"2507_CR35","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1172\/JCI107300","volume":"52","author":"CA Goresky","year":"1973","unstructured":"Goresky CA, Bach GC, Nadeau BE. On the uptake of materials by the intact liver. The transport and net removal of galactose. J Clin Invest. 1973;52:991\u20131009.","journal-title":"J Clin Invest"},{"key":"2507_CR36","doi-asserted-by":"publisher","first-page":"0","DOI":"10.1016\/j.mcpro.2023.100615","volume":"22","author":"M Svecla","year":"2023","unstructured":"Svecla M, et al. Impact of Asialoglycoprotein receptor and mannose receptor Deficiency on Murine plasma N-glycome profiles. Mol Cell Proteom. 2023;22:0\u201312.","journal-title":"Mol Cell Proteom"},{"key":"2507_CR37","doi-asserted-by":"publisher","first-page":"18608","DOI":"10.1021\/acsomega.0c00935","volume":"5","author":"M Kinoshita","year":"2020","unstructured":"Kinoshita M, Yamamoto S, Suzuki S. Age-related changes in O-Acetylation of sialic acids bound to N-Glycans of male rat serum glycoproteins and influence of Dietary Intake on their changes. ACS Omega. 2020;5:18608\u201318.","journal-title":"ACS Omega"},{"key":"2507_CR38","doi-asserted-by":"publisher","first-page":"100906","DOI":"10.1016\/j.jbc.2021.100906","volume":"297","author":"EA Visser","year":"2021","unstructured":"Visser EA, et al. Sialic acid O -acetylation: from biosynthesis to roles in health and disease. J Biol Chem. 2021;297:100906.","journal-title":"J Biol Chem"},{"key":"2507_CR39","doi-asserted-by":"crossref","unstructured":"Baumann AMT et al. 9-O-Acetylation of sialic acids is catalysed by CASD1 via a covalent acetyl-enzyme intermediate. Nat Commun. 2015;6:7673.","DOI":"10.1038\/ncomms8673"},{"key":"2507_CR40","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1021\/tx400183y","volume":"26","author":"M Darnell","year":"2013","unstructured":"Darnell M, Weidolf L. Metabolism of xenobiotic carboxylic acids: focus on Coenzyme A Conjugation, Reactivity, and interference with lipid metabolism. Chem Res Toxicol. 2013;26:1139\u201355.","journal-title":"Chem Res Toxicol"},{"key":"2507_CR41","doi-asserted-by":"publisher","first-page":"108139","DOI":"10.1016\/j.carres.2020.108139","volume":"497","author":"CD Hunter","year":"2020","unstructured":"Hunter CD, Porter EM, Cairo CW. Human neuraminidases have reduced activity towards modified sialic acids on glycoproteins. Carbohydr Res. 2020;497:108139.","journal-title":"Carbohydr Res"},{"key":"2507_CR42","doi-asserted-by":"publisher","first-page":"e018756","DOI":"10.1161\/JAHA.120.018756","volume":"10","author":"EP Demina","year":"2021","unstructured":"Demina EP, et al. Neuraminidases 1 and 3 trigger atherosclerosis by desialylating low-density lipoproteins and increasing their uptake by macrophages. J Am Heart Assoc. 2021;10:e018756.","journal-title":"J Am Heart Assoc"},{"key":"2507_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-023-02099-6","volume":"23","author":"M Svecla","year":"2024","unstructured":"Svecla M, et al. ASGR1 deficiency diverts lipids toward adipose tissue but results in liver damage during obesity. Cardiovasc Diabetol. 2024;23:1\u201317.","journal-title":"Cardiovasc Diabetol"},{"key":"2507_CR44","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1038\/s41467-024-46135-9","volume":"15","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, et al. Deficiency of ASGR1 promotes liver injury by increasing GP73-mediated hepatic endoplasmic reticulum stress. Nat Commun. 2024;15:1908.","journal-title":"Nat Commun"},{"key":"2507_CR45","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1111\/hepr.12599","volume":"46","author":"D Witzigmann","year":"2016","unstructured":"Witzigmann D, et al. Variable asialoglycoprotein receptor 1 expression in liver disease: implications for therapeutic intervention. Hepatol Res. 2016;46:686\u201396.","journal-title":"Hepatol Res"},{"key":"2507_CR46","doi-asserted-by":"publisher","first-page":"D442","DOI":"10.1093\/nar\/gky1106","volume":"47","author":"Y Perez-Riverol","year":"2019","unstructured":"Perez-Riverol Y, et al. The PRIDE database and related tools and resources in 2019: improving support for quantification data. Nucleic Acids Res. 2019;47:D442\u201350.","journal-title":"Nucleic Acids Res"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-024-02507-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-024-02507-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-024-02507-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T09:03:10Z","timestamp":1732957390000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-024-02507-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,30]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2507"],"URL":"https:\/\/doi.org\/10.1186\/s12933-024-02507-5","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,30]]},"assertion":[{"value":"5 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"428"}}